Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Serum-Free Darbepoetin Alfa in CKD
NCT00093977Phase 3Completed
- Sponsor
- Amgen
- Start
- Oct 2004
- Primary completion
- Jan 2007
- Modality
- Erythropoietins, Colony Stimulating Factors
01
Overview
Phase 3, open-label, single-arm trial of darbepoetin alfa in anemia, sponsored by Amgen. Primary endpoint: Safety Profile Comparison (SF vs RB). Started Oct 2004; status: completed.
02
Drugs
darbepoetin alfa
03
Conditions
anemia
Beyond the preview
Go deeper on NCT00093977.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00093977.